MENU

Coronavirus Webinar Series; Understanding Diagnostic Modalities for SARS-CoV-2

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Sr. Scientific Affairs Manager, Roche Diagnostic Corporation
    Biography
      Jamie obtained her Masters and PhD from the University of Georgia, in Infectious Diseases. During her graduate studies she focused on Coronavirus viral genome annotation and identification of genes associated with pathogenicity. In between her Masters and PhD program she spent time in Ghana aiding the Ministry of Health with developing a vaccine program for women and children. Following her graduate studies, she held a two-year postdoctoral position serving as the primary molecular virologist in a small diagnostic lab, while concurrently serving as an Associate professor of biology at Georgia Gwinnett College (GGC). At GGC she taught a microbiology lab and lecturer. In the diagnostic lab she utilized primary virus isolation, serum neutralization assays, and real time PCR to investigate the origin of outbreaks and the evolution of the pathogens. After her postdoctoral position, she held a brief research associate position at the University of California Davis (UC Davis) where she aided in validating diagnostic assays and looking at the role co-infections play with influenza viruses. She left UC Davis for a small biotech company located in southern California looking to relocate to Eatonton, Ga. In 2014, Jamie joined Aalto Scientific, where she served as the Director of Research. Aalto Scientific is a privately owned manufacturer of control and calibration material for clinical chemistry analyzers. During her time there she oversaw the Research and Development department's relocation serving as the primary source of knowledge transfer for all open design control projects. Due to the relocation, she was able to hire an entire R&D team that was successful in transferring more than five projects to production and two of these projects receiving FDA 510K clearance. This position enabled her to obtain a broad knowledge of clinical chemistry lab analyzers and point of care test (POC). During her time at Aalto she also enjoyed giving back by giving industry guest lectures for the BioChemical Engineering Program at UGA. In 2017, Jamie joined Roche Diagnostics in their Medical and Scientific Affairs Division in Fishers, Indiana supporting their molecular POC devices. In this current role she oversees the Medical Plan and investigator initiated studies associated with the cobas Liat, a CLIA waived molecular POC device. Additionally, she currently serves as a subject matter expert for respiratory pathogens and antimicrobial stewardship initiatives.Starting in early January, Jamie joined Roche's Emergency Response team and has been playing an integral role, from a scientific perspective, on the launch of Roche's SARS-CoV-2 diagnostics assays.

    Abstract

    Staying informed on diagnostic tools for SARS-CoV-2 can be challenging.  Because the results of the various test have different clinical implications it is important to understand the design and intended use of the available test. At the end of the session, the participant will be able to:

    Learning Objectives:

    1. Describe the diagnostic tools available for healthcare providers for SARS-CoV-2

    2. Explain how diagnostics will aid with identifying infections and surveillance

    3. Understand the difference between a molecular assay, an antigen assay, and serology test.


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    NOV 18, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    Loading Comments...
    Show Resources
    Attendees
    • See more